Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 9 of Curanex Pharmaceuticals Inc's SEC filings and found 1 convertible, 1 S-1 registration and 2 completed offerings on file for CURX. The latest dilution event on file is an offering on Sep 12, 2025. Analysis updated Sep 11, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
BCLIBrainstorm Cell Therapeutics Inc.
LTRNLantern Pharma Inc.
PTNPalatin Technologies, Inc.
BLRXBioLineRX Ltd
INABIN8bio, Inc.
TOVXTheriva Biologics, Inc.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
CMMBChemomab Therapeutics Ltd. American Depositary Share
LEXXLexaria Bioscience Corp.
MBRXMoleculin Biotech, Inc.
CALCCalciMedica, Inc.
INTIInhibitor Therapeutics, Inc.
PHIOPhio Pharmaceuticals Corp.
GTBPGT Biopharma, Inc.
ICUSeaStar Medical Holding Corporation